Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents

被引：45
|
作者：
Serebryanskaya, Tatiyana V. [1 ,2 ,3 ]
Lyakhov, Alexander S. [2 ]
Ivashkevich, Ludmila S. [2 ]
Schur, Julia [1 ]
Frias, Corazon [4 ]
Prokop, Aram [4 ]
Ott, Ingo [1 ]
机构：
[1] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med & Pharmaceut Chem, D-38106 Braunschweig, Germany
[2] Belarusian State Univ, Phys Chem Problems Res Inst, Minsk 220030, BELARUS
[3] St Petersburg State Univ, Inst Chem, St Petersburg 198504, Russia
[4] Childrens Hosp Cologne, Dept Paediat Oncol, D-50735 Cologne, Germany
来源：
DALTON TRANSACTIONS | 2015年 / 44卷 / 03期
关键词：
TRANSITION-METAL-COMPLEXES; IN-VITRO CYTOTOXICITY; CELLULAR UPTAKE; PLATINUM(II); DIPHOSPHINE; LIGANDS; GROWTH; CELLS;
D O I：
10.1039/c4dt03105a
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
Gold(I) complexes with phosphane and thiotetrazolate ligands were prepared and investigated as a new type of bioactive gold metallodrugs. The complexes triggered very efficient inhibition of the enzyme thioredoxin reductase (TrxR), which is an important molecular target for gold species. Strong cytotoxic effects were observed in MDA-MB-231 breast adenocarcinoma and HT-29 colon carcinoma cells, and the complexes also caused strong effects in vincristine resistant Nalm-6 leukemia cells. Cellular uptake studies showed elevated cellular gold levels for complexes containing a triphenylphosphane ligand, whereas trifurylphosphane analogues accumulated at significantly lower cellular concentrations.
引用
收藏
页码：1161 / 1169
页数：9
相关论文
共 50 条
  • [31] On the potential of thioredoxin reductase inhibitors for cancer therapy
    Urig, Sabine
    Becker, Katja
    SEMINARS IN CANCER BIOLOGY, 2006, 16 (06) : 452 - 465
  • [32] Evaluation of plain platinum, palladium and gold salts as inhibitors of mammalian thioredoxin reductase: Implications for clinically used drugs and the development of new anticancer agents
    Prast-Nielsen, Stefanie
    Arner, Elias
    CANCER RESEARCH, 2009, 69
  • [33] Small molecule inhibitors of mammalian thioredoxin reductase
    Cai, Wenqing
    Zhang, Liangwei
    Song, Yanlin
    Wang, Baolin
    Zhang, Baoxin
    Cui, Xuemei
    Hu, Guanming
    Liu, Yaping
    Wu, Jincai
    Fang, Jianguo
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 52 (02) : 257 - 265
  • [34] Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for antiproliferative activity
    Ng, Hu-Li
    Chen, Shangying
    Chew, Eng-Hui
    Chui, Wai-Keung
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 115 : 63 - 74
  • [35] New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights
    Fatemeh Abyar
    Leila Tabrizi
    BioMetals, 2020, 33 : 107 - 122
  • [36] New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights
    Abyar, Fatemeh
    Tabrizi, Leila
    BIOMETALS, 2020, 33 (2-3) : 107 - 122
  • [37] Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system
    Wipf, P
    Lynch, SM
    Powis, G
    Birmingham, A
    Englund, EE
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2005, 3 (21) : 3880 - 3882
  • [38] Studies toward Novel Peptidomimetic Inhibitors of Thioredoxin-Thioredoxin Reductase System
    Klossowski, Szymon
    Muchowicz, Angelika
    Firczuk, Malgorzata
    Swiech, Marta
    Redzej, Adam
    Golab, Jakub
    Ostaszewski, Ryszard
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 55 - 67
  • [39] The role of thioredoxin reductase in gold nanoparticle radiosensitization effects
    Penninckx, Sebastien
    Heuskin, Anne-Catherine
    Michiels, Carine
    Lucas, Stephane
    NANOMEDICINE, 2018, 13 (22) : 2917 - 2937
  • [40] Phosphine-bridged dinuclear gold(I) alkynyl complexes: Thioredoxin reductase inhibition and cytotoxicity
    Meyer, Andreas
    Gutierrez, Albert
    Ott, Ingo
    Rodriguez, Laura
    INORGANICA CHIMICA ACTA, 2013, 398 : 72 - 76
12345